Enfusion, Inc. (NYSE:ENFN) COO Neal Pawar Sells 21,801 Shares

Enfusion, Inc. (NYSE:ENFN) COO Neal Pawar sold 21,801 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $10.03, for a total transaction of $218,664.03. Following the sale, the chief operating officer now owns 1,143,544 shares of the company’s stock, valued at approximately $11,469,746.32. This represents a 1.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Enfusion Stock Down 0.4 %

NYSE:ENFN traded down $0.04 during trading hours on Wednesday, reaching $10.09. 241,217 shares of the company’s stock were exchanged, compared to its average volume of 382,428. Enfusion, Inc. has a 1-year low of $7.52 and a 1-year high of $10.40. The firm has a market capitalization of $1.30 billion, a price-to-earnings ratio of 253.31, a P/E/G ratio of 3.79 and a beta of 0.97. The company has a 50-day moving average of $9.34 and a 200 day moving average of $8.90.

Institutional Trading of Enfusion

Several hedge funds have recently made changes to their positions in the company. Centiva Capital LP lifted its stake in shares of Enfusion by 5.0% in the 3rd quarter. Centiva Capital LP now owns 25,596 shares of the company’s stock worth $243,000 after acquiring an additional 1,227 shares during the period. Harbor Capital Advisors Inc. lifted its stake in shares of Enfusion by 12.4% in the third quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company’s stock valued at $113,000 after purchasing an additional 1,315 shares during the period. Azora Capital LP lifted its stake in shares of Enfusion by 6.8% in the third quarter. Azora Capital LP now owns 29,827 shares of the company’s stock valued at $283,000 after purchasing an additional 1,890 shares during the period. 272 Capital LP lifted its stake in shares of Enfusion by 1.5% in the second quarter. 272 Capital LP now owns 139,180 shares of the company’s stock valued at $1,186,000 after purchasing an additional 2,000 shares during the period. Finally, California State Teachers Retirement System lifted its stake in shares of Enfusion by 11.0% in the first quarter. California State Teachers Retirement System now owns 36,002 shares of the company’s stock valued at $333,000 after purchasing an additional 3,556 shares during the period. Institutional investors and hedge funds own 81.05% of the company’s stock.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.